Belgium maps radioligand therapy capacity as pharma investment surges
Belgium is capitalising on a radiopharmaceutical sector investment boom. Pharma giants are acquiring radioligand therapy companies and expanding research areas.
Belgium is capitalising on a radiopharmaceutical sector investment boom. Pharma giants are acquiring radioligand therapy companies and expanding research areas.
A new wave of radioligand therapies is approaching. With healthcare systems and policymakers ill-equipped to handle the change, Belgium is launching an action plan.